News

The Veeva CRM suite of applications include VBioPharma, iRep, VMobile, and Vinsights. The new CRM system will facilitate Eisai to streamline its computing environment by integrating three of

The fund has been granted to the Israeli R&D subsidiary of Prolor for the biobetter version of human growth hormone, hGH-CTP. Prolor is responsible to pay back the

The agreement aims to develop adoptive cell immunotherapies that are intended to destroy metastatic melanoma cells using a patient’s tumor infiltrating lymphocytes. Under the CRADA, the companies will

The tie up allows GNS to use clinical and molecular information from a BMS clinical trial while using its own supercomputer-driven reverse-engineering and forward-simulation (REFS) platform for creating

The trials aim to determine the safety and efficacy profile of the drug in inflammatory disorders. Glenmark has also initiated another global Phase IIb trial with Revamilast in

Watson’s rosuvastatin zinc 5, 10, 20 and 40mg tablets are the generic version of Astrazeneca’s Crestor (rosuvastatin calcium) tablets. Crestor is indicated, as an adjunct to diet, to

The center offers all news, information and research on the five most common cancers in the UK. It also provides access to advice from specialist oncology advisers and

The parntership allows PRECOS to validate RCT’s existing research using its validated patient relevant cancer models like in vitro 2D and 3D assays, in vivo therapeutic evaluations and

CSPN offers specialty pharmacy services including mail distribution, clinical services, therapy management and web-based reporting. MuGard is a viscous, mucoadhesive rinse which provides a protective coating to the